New Approaches to CAR-T Therapy
The FDA first approved of chimeric antigen receptor (CAR) T cell therapy in 2017, and Penn Medicine has since been dedicated to finding further applications to the treatment.
Penn Dental Medicine and Penn Engineering Faculty Invent Nanorobotic system That Offers new options for targeting fungal infections
This research team has developed a new way to accurately target and quickly destroy fungal cells in the mouth by using nanorobots guided by magnets.
Penn Dental Medicine Researchers Develop Plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin
Henry Daniell and his team of researchers developed a new plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin.
Former Penn Engineering Faculty Develop Tau Scientific Instruments
Fang-Yen and Fouad co-founded the startup company Tau Scientific Instruments and have licensed the Penn technology.
Future mRNA Vaccine Applications Highlighted
The New York Post recently published an article discussing future applications of mRNA, including vaccinations against tuberculosis, malaria, high cholesterol, HIV, and more.
4D Molecular Therapeutics (4DMT) Acquires Rights to Penn Medicine Invented Technology from Aevitas Therapeutics
Penn spinout Aevitas Therapeutics recently executed an asset purchase agreement with California-based biotechnology company 4D Molecular Therapeutics (4DMT).
Adult Schizophrenia drug wins FDA approval
Teva Pharmaceuticals and MedinCell recently received approval from the U.S. Food and Drug Administration (FDA) for UZEDY™ (risperidone).
Penn Medicine Magazine Showcases Penn’s Drug Research and Development and Commercial Partnerships
The Spring 2023 issue of Penn Medicine Magazine describes how Penn has become a hub for drug research and development and created the infrastructure in both supporting clinical research and forging co
Technology to help Newborns in the NICU wins 2023 President’s Innovation Prize
Penn President Liz Magill awarded the 2023 President’s Innovation Prize toGabriella Daltoso, Sophie Ishiwari, Gabriela Cano, Caroline Amanda Magro, and Tifara Eliana Boyce for their project, Sonura.
Bruce Levine Speaks on the Future of CAR-T Therapies
Levine explained that there are currently six approved CAR-T therapies and he estimates that between 25,000 and 30,000 patients have been treated with those therapies globally.